Spinal Cord Infarction: TACE & HCC – A Rare Case Report
The Rising Risk of Spinal Cord Infarction Post-Hepatocellular Carcinoma Treatment: What the Future Holds Imagine a scenario: a patient, relieved to have undergone successful transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), suddenly experiences debilitating weakness and sensory loss. While TACE is a vital treatment for liver cancer, a growing body of evidence, highlighted by recent … Read more